BlueBox Precision Medicine Fund Class S Fonds
969,78
USD
-30,95
USD
-3,09
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,10% |
| Lonza Group Ltd | CH0013841017 | 6,01% |
| argenx SE | NL0010832176 | 5,94% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,45% |
| Sartorius Stedim Biotech SA | FR0013154002 | 4,99% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 4,62% |
| SpringWorks Therapeutics Inc Ordinary Shares | US85205L1070 | 4,35% |
| Blueprint Medicines Corp | US09627Y1091 | 4,32% |
| Nuvalent Inc Class A | US6707031075 | 4,14% |
| Thermo Fisher Scientific Inc | US8835561023 | 4,10% |
| Sonstige | 49,98% |